Updates in diabetes and cancer

Join us for an event discussing research for patients with both cancer and diabetes

Diabetes mellitus in patients with cancer is very common. Diabetes remains one of the commonest comorbid conditions in patients with cancer and the co-existence of cancer and diabetes can have serious implications on cancer care.

In this study day, we discuss new research relating to the field and also provide updates in the clinical management of patients with both cancer and diabetes. This study day will be beneficial for all healthcare professionals who manage patients with either cancer or diabetes mellitus.

Thursday 3 July 2025, 9am to 5pm BST

What to expect

Updates in the understanding of the relationship between diabetes and cancer
Cancer and social exclusion: treatment access
Overview of the management of patients with cancer and diabetes, including specific case studies
An update about the impact of cancer treatments on blood glucose levels
An insight into the multidisciplinary care that patients with both cancer and diabetes require

Intended audience

All healthcare professionals (health care assistants, nurses, specialist nurses, advanced nurse practitioners, physician associates, doctors in training, resident doctors, general practice and consultants) who encounter patients with cancer and/or diabetes.

Sponsor

Silver sponsor

The logo for Novo Nordisk, showing a blue cow.

Novo Nordisk have provided sponsorship to The Christie NHS Foundation Trust to cover the cost of the silver package for this meeting. They have had no influence over the meeting agenda or arrangements. In return, Novo Nordisk will have stand space and 3 Novo Nordisk employees permitted to attend the meeting.

Bronze sponsor

The logo for Recordati Rare Diseases.